| 靶点: |
IC50: 30 nM (Foxo1) |
| 体内研究: |
给糖尿病 db/db 小鼠口服 AS1842856 可抑制肝糖异生基因,导致空腹血糖水平急剧下降,而给正常小鼠口服 AS1842856 则不会影响空腹血糖水平。用 AS1842856 治疗还可抑制正常小鼠和 db/db 小鼠因注射丙酮酸而引起的血糖水平升高。 |
| 参考文献: |
1. Nagashima T, et al. Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice. Mol Pharmacol. 2010 Nov;78(5):961-70. 2. He J, et al. The resistant effect of SIRT1 in oxidative stress-induced senescence of rat nucleus pulposus cell is regulated by Akt-FoxO1 pathway. Biosci Rep. 2019 May 10;39(5). pii: BSR20190112. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.879 ml |
14.393 ml |
28.786 ml |
| 5 mM |
0.576 ml |
2.879 ml |
5.757 ml |
| 10 mM |
0.288 ml |
1.439 ml |
2.879 ml |
| 50 mM |
0.058 ml |
0.288 ml |
0.576 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |